首页>投融资

Kallyope

捐赠/众筹/授予

Kallyope Inc operates as a biotechnology company. The Company focuses on understanding gut-brain biology for transformational therapeutics to improve human health.In February 2022, Kallyope Inc closed a $236 million Series D financing co-led by Mubadala Investment Company and The Column Group.In March 2020, the company announced $112 million series C financing.In December 2018, the company expanded about $21 million and bought the Series B round total to $87 million and raised $131 million in equity capital.In February 2018, the company raised US $66 million in a series B financing round.In December 2015, the company launched with a series A financing of US $44 million

http://www.kallyope.com/

470007

基本信息

公司全称

Kallyope Inc
类型

肠脑轴机制新药开发商
产业领域

药品研发/制造、生物药
公司人数

15人以下
地址

430 E 29th St NEW YORK NEW YORK 10016-8367; US; Telephone: +19083776454;
联系电话
邮箱

info@kallyope.com
成立时间

2015-01-01

投融资

2023-05-10

捐赠/众筹/授予

820万美元

Bill and Melinda Gates Foundation
2022-02-15

D轮

2.36亿美元

Alexandria Venture Investments

Lux Capital

Casdin Capital

Hartford HealthCare Endowment

Mubadala

Polaris Partners

Illumina Ventures

Tao Capital Partners

The Column Group

Euclidean Capital

DNS Capital

StepStone Group

Parkwood

Two Sigma Ventures
2020-03-25

C轮

1.12亿美元

Lux Capital

Casdin Capital

Polaris Partners

The Column Group

Greenspring Associates

Bill and Melinda Gates Foundation
2018-12-05

B轮(B2)

2100万美元

Alexandria Venture Investments

Lux Capital

Polaris Partners

Illumina Ventures

Two Sigma Ventures

The Column Group

Euclidean Capital

Bill and Melinda Gates Foundation
2018-02-22

B轮(B1)

6600万美元

Alexandria Venture Investments

Lux Capital

Polaris Partners

Illumina Ventures

The Column Group

Euclidean Capital

Two Sigma Ventures
2015-12-10

A轮

4400万美元

Illumina

Alexandria Venture Investments

Lux Capital

Polaris Partners

The Column Group

Tony Evnin
加载更多

Kallyope

基本信息

投融资

相关投融资企业